JP2008518885A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518885A5
JP2008518885A5 JP2007537851A JP2007537851A JP2008518885A5 JP 2008518885 A5 JP2008518885 A5 JP 2008518885A5 JP 2007537851 A JP2007537851 A JP 2007537851A JP 2007537851 A JP2007537851 A JP 2007537851A JP 2008518885 A5 JP2008518885 A5 JP 2008518885A5
Authority
JP
Japan
Prior art keywords
ligand
carbon atoms
hydrocarbon chain
ligand according
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007537851A
Other languages
English (en)
Other versions
JP4831436B2 (ja
JP2008518885A (ja
Filing date
Publication date
Priority claimed from SE0402558A external-priority patent/SE0402558D0/xx
Application filed filed Critical
Priority claimed from PCT/SE2005/001592 external-priority patent/WO2006043896A1/en
Publication of JP2008518885A publication Critical patent/JP2008518885A/ja
Publication of JP2008518885A5 publication Critical patent/JP2008518885A5/ja
Application granted granted Critical
Publication of JP4831436B2 publication Critical patent/JP4831436B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (10)

  1. 次式で定義されるクロマトグラフィーリガンド。
    −R−N(R)−R−R
    式中、
    は、置換又は非置換フェニル基であり、
    は炭素原子数0〜4の炭化水素鎖であり、
    は炭素原子数1〜3の炭化水素鎖であり、
    は炭素原子数1〜5の炭化水素鎖であり、
    はOH又はHである。
  2. 、R、R及びRの1以上がOHで置換されている、請求項1記載のリガンド。
  3. が非置換フェニル基である、請求項1又は請求項2記載のリガンド。
  4. が−CH−である、請求項1乃至請求項3のいずれか1項記載のリガンド。
  5. が−CHである、請求項1乃至請求項4のいずれか1項記載のリガンド。
  6. が−CH−CH−CH−又は−CH−CH−である、請求項1乃至請求項5のいずれか1項記載のリガンド。
  7. N−ベンジル−N−メチルエタノールアミンを含む、請求項1乃至請求項6のいずれか1項記載のリガンド。
  8. 請求項1乃至請求項7のいずれか1項記載の複数のリガンドを担体に固定することを含む、分離マトリックスの調製方法。
  9. 請求項8記載の方法で調製されたマトリックスであって、前記担体が実質的に球状の粒子のような粒子を含む、マトリックス。
  10. 前記担体がメンブラン構造を含む、請求項9記載のマトリックス。
JP2007537851A 2004-10-21 2005-10-21 クロマトグラフィーリガンド Active JP4831436B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0402558A SE0402558D0 (sv) 2004-10-21 2004-10-21 A process for the purification of antibodies
SE0402558-1 2004-10-21
SE0402910-4 2004-11-26
SE0402910 2004-11-26
PCT/SE2005/001592 WO2006043896A1 (en) 2004-10-21 2005-10-21 Chromatography ligand

Publications (3)

Publication Number Publication Date
JP2008518885A JP2008518885A (ja) 2008-06-05
JP2008518885A5 true JP2008518885A5 (ja) 2008-11-27
JP4831436B2 JP4831436B2 (ja) 2011-12-07

Family

ID=36203226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007537850A Active JP5064225B2 (ja) 2004-10-21 2005-10-21 抗体精製法
JP2007537851A Active JP4831436B2 (ja) 2004-10-21 2005-10-21 クロマトグラフィーリガンド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007537850A Active JP5064225B2 (ja) 2004-10-21 2005-10-21 抗体精製法

Country Status (12)

Country Link
US (5) US7867784B2 (ja)
EP (2) EP1807205B1 (ja)
JP (2) JP5064225B2 (ja)
KR (2) KR101243601B1 (ja)
AU (2) AU2005296352B2 (ja)
BR (2) BRPI0518216C8 (ja)
CA (2) CA2583578C (ja)
DK (1) DK1827691T3 (ja)
ES (1) ES2612572T3 (ja)
PL (1) PL1827691T3 (ja)
RU (3) RU2541429C2 (ja)
WO (2) WO2006043896A1 (ja)

Families Citing this family (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005073711A2 (en) 2004-01-20 2005-08-11 Pall Corporation Chromatographic material for the absorption of proteins at physiological ionic strength
CA2583578C (en) * 2004-10-21 2014-04-01 Ge Healthcare Bio-Sciences Ab Chromatography ligand
US9082456B2 (en) 2005-01-31 2015-07-14 The Invention Science Fund I Llc Shared image device designation
US8902320B2 (en) 2005-01-31 2014-12-02 The Invention Science Fund I, Llc Shared image device synchronization or designation
US20060170956A1 (en) 2005-01-31 2006-08-03 Jung Edward K Shared image devices
US9910341B2 (en) 2005-01-31 2018-03-06 The Invention Science Fund I, Llc Shared image device designation
US9124729B2 (en) 2005-01-31 2015-09-01 The Invention Science Fund I, Llc Shared image device synchronization or designation
US9325781B2 (en) 2005-01-31 2016-04-26 Invention Science Fund I, Llc Audio sharing
US8606383B2 (en) 2005-01-31 2013-12-10 The Invention Science Fund I, Llc Audio sharing
US20060174203A1 (en) 2005-01-31 2006-08-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Viewfinder for shared image device
US9489717B2 (en) 2005-01-31 2016-11-08 Invention Science Fund I, Llc Shared image device
TW200639190A (en) * 2005-02-04 2006-11-16 Showa Denko Kk Packing material for ion chromatography
US9001215B2 (en) 2005-06-02 2015-04-07 The Invention Science Fund I, Llc Estimating shared image device operational capabilities or resources
US9967424B2 (en) 2005-06-02 2018-05-08 Invention Science Fund I, Llc Data storage usage protocol
US10003762B2 (en) 2005-04-26 2018-06-19 Invention Science Fund I, Llc Shared image devices
US9451200B2 (en) 2005-06-02 2016-09-20 Invention Science Fund I, Llc Storage access technique for captured data
US9942511B2 (en) 2005-10-31 2018-04-10 Invention Science Fund I, Llc Preservation/degradation of video/audio aspects of a data stream
US8681225B2 (en) 2005-06-02 2014-03-25 Royce A. Levien Storage access technique for captured data
US9093121B2 (en) 2006-02-28 2015-07-28 The Invention Science Fund I, Llc Data management of an audio data stream
US9819490B2 (en) 2005-05-04 2017-11-14 Invention Science Fund I, Llc Regional proximity for shared image device(s)
NZ611859A (en) * 2006-04-05 2014-12-24 Abbvie Biotechnology Ltd Antibody purification
EP2043767B1 (en) 2006-07-14 2020-03-25 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7691980B2 (en) 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US8092683B2 (en) * 2007-01-10 2012-01-10 Ge Healthcare Bio-Sciences Ab Multi-modal ion exchange chromatography resins
AU2008279841B2 (en) 2007-07-25 2013-05-02 Cytiva Bioprocess R&D Ab Separation matrix
JP5778389B2 (ja) * 2007-10-26 2015-09-16 旭化成ケミカルズ株式会社 たんぱく質の精製方法
WO2009058769A1 (en) * 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
US8188242B2 (en) * 2008-04-08 2012-05-29 Bio-Rad Laboratories, Inc. Chromatography purification of antibodies
DE102008018732B4 (de) * 2008-04-14 2022-06-09 Sartorius Stedim Biotech Gmbh Verfahren zur Stofftrennung unter Verwendung einer Cellulosehydrat-Membran in der Größenausschlusschromatographie
DE102008055821A1 (de) * 2008-04-14 2009-10-15 Sartorius Stedim Biotech Gmbh Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung davon
DE102008018734B4 (de) * 2008-04-14 2013-03-21 Sartorius Stedim Biotech Gmbh Hydrophobe Cellulose-Membran, Verfahren zu ihrer Herstellung und ihre Verwendung in der hydrophoben Interaktionschromatographie
FR2931838B1 (fr) * 2008-06-02 2010-06-11 Millipore Corp Installation pour traiter un liquide biologique.
WO2010030222A1 (en) * 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal with multimodal anion exchangers in the presence of protein-excluded zwitterions
EP2360183B1 (en) * 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Antibody purification method by mixed mode chromatography utilizing an arginine-containing loading solution
FR2940145B1 (fr) 2008-12-24 2011-03-25 Millipore Corp Chariot et installation de traitement d'un liquide biologique
JP2010158624A (ja) * 2009-01-08 2010-07-22 Asahi Kasei Chemicals Corp 多孔質吸着膜、及び当該多孔質吸着膜を用いたたんぱく質の精製方法
FR2941385B1 (fr) 2009-01-23 2011-04-01 Millipore Corp Procede pour fournir un circuit pour liquide biologique et circuit obtenu.
WO2011001963A1 (ja) * 2009-07-03 2011-01-06 旭化成ケミカルズ株式会社 多孔質基材に固定されたグラフト鎖に結合しているアミノ基及びアルキル基を有する多孔膜を用いた抗体の精製方法
CA2769040A1 (en) 2009-07-28 2011-02-03 Instraction Gmbh Specific sorbent for binding proteins and peptides, and separation method using the same
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
FR2955119B1 (fr) 2010-01-13 2012-12-28 Millipore Corp Circuit pour liquide biologique
CN102905718A (zh) 2010-05-25 2013-01-30 弗·哈夫曼-拉罗切有限公司 纯化多肽的方法
FR2960794B1 (fr) 2010-06-08 2012-07-27 Millipore Corp Dispositif pour une installation de traitement de liquide biologique
FR2960796B1 (fr) 2010-06-08 2014-01-24 Millipore Corp Dispositif pour une installation de traitement de liquide biologique
FR2960795B1 (fr) 2010-06-08 2012-07-27 Millipore Corp Dispositif pour une installation de traitement de liquide biologique
FR2961713B1 (fr) 2010-06-23 2012-08-10 Millipore Corp Poche pour circuit d'une installation de traitement de liquide biologique
FR2961711B1 (fr) 2010-06-23 2012-08-17 Millipore Corp Poche pour circuit d'une installation de traitement de liquide biologique
WO2012015908A2 (en) 2010-07-30 2012-02-02 Millipore Corporation Chromatography media and method
FR2963573B1 (fr) 2010-08-03 2012-08-31 Millipore Corp Chariot de pompage pour une installation de traitement de liquide biologique
CN103201003B (zh) * 2010-09-20 2016-04-13 Abbvie公司 采用模拟移动床色谱纯化抗体
EP2655412B1 (en) * 2010-12-21 2018-01-17 F. Hoffmann-La Roche AG Isoform enriched antibody preparation and method for obtaining it
FR2973396B1 (fr) 2011-03-28 2013-05-10 Millipore Corp Installation de traitement de liquide biologique
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
EP2570184A1 (en) * 2011-09-15 2013-03-20 InstrAction GmbH Sorbent comprising on its surface an aromatic ring system having an anionic or deprotonizable group for the purification of organic molecules
EP2570185A1 (en) * 2011-09-15 2013-03-20 InstrAction GmbH Sorbent comprising an aromatic ring system on its surface for the purification of organic molecules
US8802448B2 (en) 2011-07-27 2014-08-12 Pall Corporation Mixed mode ligands
EP2578286A1 (en) * 2011-10-04 2013-04-10 Merck Patent GmbH Method and apparatus for chromatographic purification
PT2768857T (pt) * 2011-10-19 2020-01-27 Novimmune Sa Métodos para purificar anticorpos
US9309282B2 (en) 2011-10-19 2016-04-12 Bio-Rad Laboratories, Inc. Solid phase for mixed-mode chromatographic purification of proteins
WO2013066707A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Chromatography process for resolving heterogeneous antibody aggregates
EP2782925B1 (en) * 2011-11-23 2024-03-06 Sanofi Protein purification using bis-tris buffer
WO2013075740A1 (en) * 2011-11-23 2013-05-30 Sanofi Antibody purification method
CN104812491B (zh) 2012-03-08 2018-06-19 生物辐射实验室股份有限公司 阴离子交换-疏水性混合模式
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
RU2501008C1 (ru) * 2012-06-14 2013-12-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической иммунологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИКИ" СОРАМН) СПОСОБ АФФИННОГО ВЫДЕЛЕНИЯ АУТОАНТИТЕЛ КЛАССА IgG К ИММУНОРЕГУЛЯТОРНОМУ ЦИТОКИНУ TNF
FR2993572B1 (fr) 2012-07-23 2016-04-15 Emd Millipore Corp Circuit pour liquide biologique comportant une vanne a pincement
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CN104603144A (zh) * 2012-09-03 2015-05-06 株式会社钟化 混合模式抗体亲和分离基质和使用其的纯化方法及靶分子
RU2015114330A (ru) 2012-09-17 2016-11-10 У.Р. Грейс Энд Ко.-Конн. Хроматографические среды и устройства
JP6397422B2 (ja) * 2012-11-13 2018-09-26 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ マルチモーダルアニオン交換マトリックス
EP4089101A1 (en) 2013-02-26 2022-11-16 Merck Millipore Ltd Mixed-mode chromatography membranes
SG10201709131UA (en) * 2013-03-08 2017-12-28 Genzyme Corp Continuous purification of therapeutic proteins
US10023608B1 (en) * 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
PL2970378T3 (pl) 2013-03-15 2021-12-06 Biogen Ma Inc. Chromatografia oddziaływań hydrofobowych białek w warunkach bez soli
BR112015027812B1 (pt) * 2013-05-06 2021-03-30 Sanofi Método para a purificação de uma proteína a partir de uma solução
EP3048109A4 (en) 2013-09-17 2017-04-19 Kaneka Corporation Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
KR101891522B1 (ko) 2013-12-12 2018-08-24 이엠디 밀리포어 코포레이션 아크릴아미드 함유 필터를 사용한 단백질 분리
SG11201605712SA (en) 2014-01-16 2016-08-30 Grace W R & Co Affinity chromatography media and chromatography devices
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
US20240100450A9 (en) * 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
JP6653654B2 (ja) * 2014-01-17 2020-02-26 レプリゲン・コーポレイションRepligen Corporation クロマトグラフィーカラムの滅菌
TWI709569B (zh) * 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
EP2986625B1 (en) 2014-03-14 2020-03-11 Bio-rad Laboratories, Inc. Mixed mode ligands
ES2929099T3 (es) 2014-05-02 2022-11-24 Grace W R & Co Material de soporte funcionalizado y métodos de fabricación y uso de material de soporte funcionalizado
US10155799B2 (en) * 2014-07-21 2018-12-18 Merck Sharp & Dohme Corp. Chromatography process for purification of insulin and insulin analogs
EP3230299A1 (en) 2014-12-08 2017-10-18 EMD Millipore Corporation Mixed bed ion exchange adsorber
BR112017026193B1 (pt) 2015-06-05 2021-09-14 W.R. Grace & Co-Conn Adsorventes, método de produção dos adsorventes e uso dos adsorventes
WO2017174422A1 (en) * 2016-04-06 2017-10-12 Ge Healthcare Bioprocess R&D Ab Chromatography matrix
MX2019000935A (es) 2016-08-16 2019-07-04 Regeneron Pharma Metodos para cuantificar anticuerpos individuales de una mezcla.
CN109923411B (zh) 2016-10-25 2022-05-31 里珍纳龙药品有限公司 用于色谱数据分析的方法和系统
WO2018092691A1 (ja) * 2016-11-18 2018-05-24 Jnc株式会社 抗体の精製方法
SG11201905510XA (en) 2017-01-30 2019-08-27 Regeneron Pharma Compositions and methods for reducing bioburden in chromatography
US11534780B2 (en) 2017-11-14 2022-12-27 General Electric Company Spray nozzle device for delivering a restorative coating through a hole in a case of a turbine engine
US11161128B2 (en) 2017-11-14 2021-11-02 General Electric Company Spray nozzle device for delivering a restorative coating through a hole in a case of a turbine engine
WO2019152977A2 (en) 2018-02-05 2019-08-08 Bio-Rad Laboratories, Inc. Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
CN111818996B (zh) 2018-03-05 2022-09-09 欧洲手性技术股份公司 用于生物分离的复合材料
US20210106974A1 (en) 2018-03-05 2021-04-15 Chiral Technologies Europe Sas Composite materials for bioseparations
WO2019173731A1 (en) * 2018-03-08 2019-09-12 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resin
WO2019175412A2 (en) * 2018-03-15 2019-09-19 Klawego Gmbh & Co. Kg Composite materials for the depletion of contaminants from solutions
TW202005694A (zh) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
US11045773B2 (en) 2018-08-31 2021-06-29 Pall Corporation Salt tolerant porous medium
US10737259B2 (en) 2018-08-31 2020-08-11 Pall Corporation Salt tolerant anion exchange medium
CN113574383A (zh) 2019-03-27 2021-10-29 思拓凡瑞典有限公司 分离生物分子的方法
WO2021046284A1 (en) * 2019-09-05 2021-03-11 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resins
EP4019125A1 (en) 2020-12-22 2022-06-29 Sartorius Stedim Biotech GmbH Chromatographic material and method of producing same
GB202110014D0 (en) 2021-07-12 2021-08-25 Cytiva Bioprocess R & D Ab A method for separating adeno-associated virus capsids, compositions obtained by said method and uses thereof
CA3236293A1 (en) 2021-12-07 2023-06-15 Cytiva Bioprocess R&D Ab Separation matrix and methods for separating target molecules
GB202202777D0 (en) 2022-03-01 2022-04-13 Cytiva Bioprocess R & D Ab A method for separating supercoiled plasmid DNA
GB202206123D0 (en) 2022-04-27 2022-06-08 Cytiva Bioprocess R & D Ab A pre-screening method and a method for separating adeno-associated virus capsids
GB202214280D0 (en) 2022-09-29 2022-11-16 Cytiva Vioprocess R&D Ab Chromatography ligand and chromatography material, and uses thereof
GB202215814D0 (en) 2022-10-26 2022-12-07 Cytiva Bioprocess R & D Ab A chromatography device, system, and use thereof for analytic separation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2405555A (en) * 1946-08-13 Manufacture of heterocyclic bases
US3467656A (en) * 1967-09-06 1969-09-16 Hoffmann La Roche 4-aryl-3,1-benzoxazine-2-thione
SE8204810L (sv) 1982-08-23 1984-02-24 Pharmacia Fine Chemicals Ab Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4983722A (en) * 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
US5322859A (en) * 1993-02-08 1994-06-21 University Of Iowa Research Foundation Antiglaucoma drug composition and method
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5652348A (en) * 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
GB9519197D0 (en) * 1995-09-20 1995-11-22 Affinity Chromatography Ltd Novel affinity ligands and their use
US6117996A (en) 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
SE9601368D0 (sv) * 1996-04-11 1996-04-11 Pharmacia Biotech Ab Process for the production of a porous cross-linked polysaccharide gel
CA2876986C (en) * 1996-08-30 2017-08-29 Dpx Holdings B.V. Isolation of immunoglobulins
SE9700383D0 (sv) * 1997-02-04 1997-02-04 Pharmacia Biotech Ab An adsorption/separation method and a medium for adsorption/separation
US5908960A (en) * 1997-05-07 1999-06-01 Smithkline Beecham Corporation Compounds
DE60045931D1 (de) * 1999-07-07 2011-06-16 Zymogenetics Inc Menschliches Rezeptor für Zytokine
SE9904197D0 (sv) * 1999-11-22 1999-11-22 Amersham Pharm Biotech Ab A method for anion exchange adsorption on matrices carrying mixed mode ligands
TWI248432B (en) * 2000-06-08 2006-02-01 Kaneka Corp Process for the production of sulfonic esters
SE0004932D0 (sv) 2000-12-31 2000-12-31 Apbiotech Ab A method for mixed mode adsorption and mixed mode adsorbents
US20020110495A1 (en) * 2001-01-05 2002-08-15 Denis Hunt Devices and methods for purification
US6652853B2 (en) * 2001-03-08 2003-11-25 Ludwig Institute For Cancer Research Method for treating cancer using A33 specific antibodies and chemotherapeutic agents
DE10155984A1 (de) 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
AU2004215653B2 (en) * 2003-02-28 2011-03-17 Lonza Biologics Plc. Antibody purification by protein A and ion exchange chromatography
EP1718386A1 (en) * 2004-02-27 2006-11-08 GE Healthcare Bio-Sciences AB A process for the purification of antibodies
WO2006033634A1 (en) 2004-09-22 2006-03-30 Ge Healthcare Bio-Sciences Ab Method of preparing a chromatography matrix
US9266041B2 (en) * 2004-10-21 2016-02-23 Ge Healthcare Bio-Sciences Ab Chromatography ligand
CA2583578C (en) 2004-10-21 2014-04-01 Ge Healthcare Bio-Sciences Ab Chromatography ligand
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers

Similar Documents

Publication Publication Date Title
JP2008518885A5 (ja)
JP2009518277A5 (ja)
JP2009040728A5 (ja)
JP2010517318A5 (ja)
ATE497034T1 (de) Verfahren zur herstellung von trägerkatalysatoren aus metallbeladenen kohlenstoffnanoröhrchen
JP2009526141A5 (ja)
JP2009541403A5 (ja)
JP2007291061A5 (ja)
JP2007039431A5 (ja) 物質、発光素子用材料、発光素子、発光装置及び電子機器
JP2009508710A5 (ja)
JP2009536150A5 (ja)
WO2006081035A3 (en) Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
JP2007051233A5 (ja)
JP2006527170A5 (ja)
JP2010502476A5 (ja)
EP1849836A3 (en) Compound having polymethine-chain structure, image forming material, planographic printing plate precursor, and image forming method using the same, method of making planographic printing plate, and planographic printing method
JP2008503754A5 (ja)
JP2008521811A5 (ja)
JP2020531248A5 (ja)
JP2010508141A5 (ja)
JP2014524888A5 (ja)
JP2005515295A5 (ja)
JP2007045816A5 (ja) カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法
JP2007176917A5 (ja)
JP2022008106A5 (ja)